sleuth
Livin' Like Thanksgivin'
NitroMed tested the cardiac drug in blacks after the FDA rejected BiDil for general use. The Lexington, Mass., firm said the study was warranted because early evidence suggested that African Americans might benefit from the pill.
But some scientists say it's doubtful that only African Americans will respond to BiDil.
"It is not like one group has all the bad genes," said Neil Risch, a UC San Francisco geneticist. "They are pretty well distributed."
The drug has stirred concern outside the world of medicine as well.
By approving a drug for one race, "you are giving biological reality to … a cultural prejudice, and that can be dangerous," said Gregory Dorr, an expert in the history of medicine at the University of Alabama. "The last time something was labeled for blacks, it was water coolers and restrooms."
linkage: http://www.latimes.com/business/la-fi-bidil16jun16,0,4834657.story?coll=la-home-business
This is stupid. Science is science. The drug company is doing the right thing by saying "we only tested this on blacks, so it should only be available on blacks for now."
If a bunch of tards have problems with it, then offer to finance the testing for other races.